The Board of Directors of Zhejiang Hisoar Pharmaceutical Co., Ltd. has authorized a buyback plan on February 2, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.19 CNY | -1.43% | -2.67% | -13.91% |
Apr. 28 | Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 18 | Hisoar Pharma's Unit Passes German Health Regulator's Inspection | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.91% | 1.37B | |
+37.78% | 723B | |
+31.18% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.45% | 244B | |
-4.66% | 208B | |
+10.07% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- 002099 Stock
- News Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Zhejiang Hisoar Pharmaceutical Co., Ltd. authorizes a Buyback Plan.